Jet Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.16%
- Profit Growth 2.43%
- Ebitda 78.30%
- Net Worth 7.50%
- Total Assets 7.73%
About Jet Pharma
Jet Pharma Limited (JPL) is a Public Limited Indian Non-Government Company incorporated in India on 06 October 1988 and has a history of 36 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Appreal & Fashion Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nirav Shah, Aditya Shah, Supriya Shah, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U17100MH1988PLC049102
-
Company No.
049102
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
06 Oct 1988
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jet Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirav Shah
|
Director | 14-Jul-1994 | Current |
|
Aditya Shah
|
Director | 14-Mar-2014 | Current |
|
Supriya Shah
|
Director | 12-Aug-2022 | Current |
|
Devina Shah
|
Director | 14-Jul-1994 | Current |
Financial Performance of Jet Pharma.
Jet Pharma Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.16% increase. The company also saw a slight improvement in profitability, with a 2.43% increase in profit. The company's net worth moved up by a moderate rise of 7.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jet Pharma?
In 2021, Jet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Express Pharma LimitedNirav Shah and Devina Shah are mutual person
-
Luckystar Distributors Limited
Nirav Shah and Devina Shah are mutual person
-
Speedking Pharma Private Limited
Nirav Shah and Devina Shah are mutual person
-
Luckystar Pharma Private Limited
Nirav Shah and Devina Shah are mutual person
-
Celebrate Services Private Limited
Nirav Shah, Aditya Shah and 2 more are mutual person
-
Sevenstar Realtek Private Limited
Nirav Shah, Aditya Shah and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jet Pharma?
Unlock and access historical data on people associated with Jet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
